BEULAH JOSHUA: Open Payments
NPI 1689211609 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 28 payments from 10 companies in 2025. Trend: 2023 $498 · 2024 $700 · 2025 $520
Food & beverage: $513Education: $8
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $226 |
| Vanda Pharmaceuticals Inc. | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Biogen, Inc. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
Products named: REXULTI, FANAPT, ABILIFY ASIMTUFII, COBENFY, ABILIFY MAINTENA, UZEDY, ZURZUVAE, INGREZZA.
Industry payments across MO — which companies pay providers there.
